SNCA and Parkinson disease: As such, it is possible that DAM in PD engage in phagocytic clearance of the α-synuclein Lewy bodies accumulated in the SNpc—something in principle that may be neuroprotective if employed therapeutically at the appropriate spatiotemporal point.